Biora Therapeutics Inc (BIOR) — Financial Flexibility Index
Biora Therapeutics Inc (BIOR) has a Financial Flexibility Index of -0.07x as of September 2024. Free cash flow of $-8.71 Million (operating CF $-8.73 Million minus capex $19.00K) represents 0% of total liabilities ($121.13 Million). Check Biora Therapeutics Inc (BIOR) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biora Therapeutics Inc Financial Flexibility Index (2018–2023)
Historical Financial Flexibility Index trend for Biora Therapeutics Inc across 6 annual periods. See Biora Therapeutics Inc (BIOR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biora Therapeutics Inc (2018–2023)
Year-by-year free cash flow to debt coverage for Biora Therapeutics Inc. For the full company profile including market capitalisation, see BIOR stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.36x | $-48.40 Million | $-48.50 Million | $132.64 Million | ▲ +10.6% |
| 2022 | -0.41x | $-63.62 Million | $-64.42 Million | $155.81 Million | ▲ +52.5% |
| 2021 | -0.86x | $-166.63 Million | $-167.49 Million | $193.81 Million | ▼ -39.8% |
| 2020 | -0.62x | $-160.80 Million | $-165.74 Million | $261.43 Million | ▼ -11.5% |
| 2019 | -0.55x | $-102.40 Million | $-106.12 Million | $185.60 Million | ▼ -40.3% |
| 2018 | -0.39x | $-60.29 Million | $-65.13 Million | $153.37 Million | — |